Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125244852 | 12524485 | 2 | F | 20160725 | 20160704 | 20160806 | EXP | US-AUROBINDO-AUR-APL-2016-08459 | AUROBINDO | MAITI A, ET AL.. ANTINEOPLASTICS: MELANONYCHIA: CASE REPORT. REACTIONS WEEKLY. 2016;1611:23 | 32.00 | YR | F | Y | 0.00000 | 20160806 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125244852 | 12524485 | 1 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK, THREE CYCLES | U | U | 84773 | ||||||||
125244852 | 12524485 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK, THREE CYCLES | U | U | 0 | ||||||||
125244852 | 12524485 | 3 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | UNK, THREE CYCLES | U | U | 0 | ||||||||
125244852 | 12524485 | 4 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | UNK, THREE CYCLES | U | U | 0 | ||||||||
125244852 | 12524485 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK, THREE CYCLES | U | U | 0 | ||||||||
125244852 | 12524485 | 6 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Unknown | UNK, THREE CYCLES | U | U | 0 | ||||||||
125244852 | 12524485 | 7 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | Unknown | UNK | U | U | 0 | ||||||||
125244852 | 12524485 | 8 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125244852 | 12524485 | 1 | B-cell lymphoma |
125244852 | 12524485 | 2 | B-cell lymphoma |
125244852 | 12524485 | 3 | B-cell lymphoma |
125244852 | 12524485 | 4 | B-cell lymphoma |
125244852 | 12524485 | 5 | B-cell lymphoma |
125244852 | 12524485 | 6 | B-cell lymphoma |
125244852 | 12524485 | 7 | Product used for unknown indication |
125244852 | 12524485 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125244852 | 12524485 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125244852 | 12524485 | Nail pigmentation | |
125244852 | 12524485 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |